Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3199 results found
Expand All
Apply All
3199 results found

“We’re closer than people think.”
Share
Bio.News  •  April 10, 2020
The bad news? There’s been a detection of bird flu in the United States. The even worse news? Dolly Parton is unaware that over 50+ biotech innovators are working around the clock to beat COVID-19. Help us spread the word by RETWEETING our message to Dolly! You can do so by clicking here.As for the good news, we know how to protect against animal diseases. And we’re very close to COVID-19 treatments and vaccines. Here’s a quick 662 words, or about 3 minutes, 20 seconds.
Read More

Letter Urging USDA to Include Biofuels in COVID-19 Economic Relief
Share
Agriculture & Environment, Sustainable Fuels  •  Letters, Testimony & Comments  •  April 9, 2020
Given the impact the economic downturn has had on all biofuel technologies, we request that USDA ensures all advanced and cellulosic biofuels are eligible to receive assistance from the additional funds provided to the Commodity Credit Corporation (CCC) by the Coronavirus Aid, Relief, and Economic Stabilization (CARES) Act. 
Read More

BIO's Coronavirus Hub has 1,000+ users
Share
Bio.News  •  April 9, 2020
Today marks 100 days since China announced the detection of the coronavirus (H/T Axios/The Guardian).  We also have a milestone to report: the BIO Coronavirus Hub has 1,000 users. More on that, plus how we can ensure the continuity of the food supply chain, in around 900 words, or 4-and-a-half minutes.P.S. We're thinking of our readers celebrating Passover, Holy Week, and Easter. With so much going on in our industry, we are continuing business as usual at Good Day BIO in the coming days, but we are wishing you all a joyous holiday and hope you enjoy time with your families, virtually.
Read More

2 cool things: animal biotech and antibodies
Share
Bio.News  •  April 8, 2020
Congratulations to the several BIO members who were included in Endpoints News’ 20 Under 40 in Biopharma! We’re proud to be working with so many next-generation biotech leaders.  Today, we take a closer look at how animal biotech policy can help us fight coronavirus, as well as answer some of your questions about antibodies, in about 860 words, just over 4 minutes.
Read More

BIO Letter to White House on Need for Animal Biotech Reform in Wake of COVID-19
Share
Food & Farm Innovation  •  Letters, Testimony & Comments  •  April 7, 2020
As part of the Administration’s comprehensive response to the unprecedented health and economic impacts from the COVID-19 pandemic, the Biotechnology Innovation Organization (BIO) respectfully requests that the U.S. government immediately reform its approach to oversight of animals with intentional genomic alterations. We are calling on the White House to direct the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop and execute a memorandum of understanding (MOU) clarifying regulatory responsibilities over these animals within 30 days.
Read More

On World Health Day, a reminder of why collaboration matters
Share
Bio.News  •  April 7, 2020
It’s World Health Day, a public health awareness day promoted by the World Health Organization (WHO)—and this year’s theme celebrates nurses and midwives, many of whom are caring for patients on the frontlines of the COVID-19 pandemic. We’re thinking of you today, and every day, as we race to find therapeutics and vaccines and deliver diagnostics and other tools and supplies for you to do your jobs safely. Today, we’re looking at one example of how international collaboration is doing just that, plus, why you don’t need to worry about running out of food. Here are 850 words, just over 4 minutes.
Read More

Fighting coronavirus, together
Share
Bio.News  •  April 6, 2020
It’s a new week. Today, we’re taking a look at how several BIO members are collaborating on COVID-19—from developing innovative science to sending their employees to the front lines of the fight. Here are about 720 words, or 3 minutes, 30 seconds.
Read More

Meet the sickle cell saviors
Share
Bio.News  •  April 4, 2020
It’s the weekend, and we hope you are finding a little rest, relaxation, and joy at home.  In today’s Special Weekend Edition of Good Day BIO, we’re taking a brief break from all the news surrounding COVID-19 to share the latest episode of the I AM BIO podcast: Sickle Cell Saviors. Sickle cell disease is an inherited red blood cell disease that can cause debilitating pain and lifelong complications. In the United States, the disease disproportionately affects African Americans.  In November, the Food and Drug Administration (FDA) approved Global Blood Therapeutics’ Oxbryta, the first drug that attacks the underlying cause of sickle cell disease.  In this episode, you'll hear from three inspiring guests: Global Blood Therapeutics CEO Dr. Ted Love, who talks about the history of the disease and how GBT’s diverse, majority-minority workforce drove this groundbreaking discovery. Mapillar Dahn, Founder of the My Three Sicklers Sickle Cell Foundation, who has three daughters born with the disease. She talks about the realities of discrimination in U.S. health systems. Dr. Helen Torley, CEO of Halozyme and the leader of BIO’s Workforce Development, Diversity and Inclusion Committee, who explains how BIO is working to create a new generation of diverse leadership in the biotech industry, and how the sickle cell breakthrough shows why it's important for biotech workforces to represent the communities they serve. Why it matters: Whether it’s fighting Covid-19 or looking for innovative ways to treat other devastating diseases, providing hope and saving lives is what the men and women of the biopharmaceutical industry strive for every day. Listen to the full podcast by visiting www.bio.org/podcast or wherever you get your podcast fix including Apple, Google, and Spotify.  Learn more about why diversity matters in biotech at www.rightmixmatters.org.   Learn more about MTS Sickle Cell Foundation at www.mythreesicklers.org.   We’ll be back on Monday with the news. 
Read More

2020 BIO International Convention Now Fully Digital
Share
Press Release  •  April 3, 2020
The Biotechnology Innovation Organization (BIO) announced today it will be moving the 2020 BIO International Convention scheduled for June 8-11 in San Diego to an online platform, in lieu of an in-person event for this year. The decision was based on the impact of COVID-19, the safety of the attendees and global health recommendations regarding large, in-person gatherings. “The coronavirus is an urgent focus for the biotechnology industry as we work tirelessly to combat this public health threat,” said Jim Greenwood, BIO President & CEO. “Now, more than ever, it’s critical for the biotechnology world to convene and forge collaborations, partnerships and research to advance innovations for our patients and to solve our most timely global issues.”   BIO Digital 2020 will focus on partnerships and virtual collaboration with its BIO One-on-One Partnering system allowing attendees to schedule virtual meetings using their preferred method—whether that is a teleconference system, video meeting service, or another medium—to maximize their business development and licensing potential. The new format will include expert-level educational content focused on the most pressing industry topics including COVID-19, infectious diseases, vaccine development, digital health, business development, and the latest therapeutic advancements in biotech. Panels will run across four days, mixing live and on-demand sessions. BIO remains committed to amplifying the industry’s efforts to develop solutions for patients. In response to the COVID-19 pandemic, BIO has created a web page dedicated to resources for the biopharmaceutical industry. The Business Resource Center features the most up-to-date information on how to maintain business continuity during the pandemic. The center’s newest feature is the Coronavirus Hub, a platform that will enable users to post requests for urgently needed resources and announce the availability of supplies and capacity. In 2021, the Convention…
Read More

The 2020 BIO International Convention will be fully digital
Share
Bio.News  •  April 3, 2020
It's Friday, and we've got a big announcement today. Here's a quick 575 words (3 minutes) with news on the 2020 BIO International Convention, as well as some more links to industry news. 
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 239
  • 240
  • 241
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO